Equities

EUDA Health Holdings Ltd

EUDA:NAQ

EUDA Health Holdings Ltd

Actions
Health CareHealth Care Providers
  • Price (USD)4.39
  • Today's Change0.29 / 7.07%
  • Shares traded92.61k
  • 1 Year change+225.19%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

EUDA Health Holdings Limited is a health technology company. The Company operates a southeast Asian digital healthcare ecosystem. Its unified artificial intelligence platform assesses patients' medical history, triages conditions, digitally connects patients with clinicians, and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. Its medical urgent care services provide healthcare assistance and medical evacuation to individual and corporate clients. Its property management service covers the management of properties, such as condominiums and shopping malls. Its services include e-triage, GP consult, e-medical certificates, and medical prescriptions. Its EUDA platform provides medical services from primary to post-surgery care and ongoing preventive healthcare for clients, regardless of the level of healthcare required.

  • Revenue in USD (TTM)3.81m
  • Net income in USD-17.99m
  • Incorporated2021
  • Employees106.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
EUDA:NAQ since
announced
Transaction
value
CK Health Plus Sdn BhdDeal completed06 May 202406 May 2024Deal completed145.25%15.00m
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Harvard Bioscience, Inc.101.13m-10.68m112.08m391.00--1.67--1.11-0.2471-0.24712.351.540.74411.646.88258,631.70-7.86-3.29-9.44-3.8958.3956.67-10.56-4.570.9416-1.310.3467---0.9573-1.4564.11--18.10--
TELA Bio Inc64.74m-42.11m112.78m227.00--26.44--1.74-1.71-1.712.640.11630.83761.487.62285,215.80-54.48-52.00-66.54-60.9568.6165.32-65.04-107.652.52-8.690.9343--41.1347.85-5.35---17.12--
908 Devices Inc.52.69m-37.99m123.72m230.00--0.7907--2.35-1.15-1.151.604.520.25111.544.95229,069.60-18.11-14.16-20.12-15.3552.3253.02-72.10-64.254.23--0.00--7.2117.89-8.45--22.98--
KORU Medical Systems Inc30.82m-11.76m131.60m82.00--7.03--4.27-0.2574-0.25740.67420.40820.97372.946.50375,817.30-37.15-17.60-43.48-20.2962.4959.44-38.16-21.703.27--0.0195--2.2310.44-58.65--11.10--
Pro-Dex Inc56.80m5.21m139.11m148.0027.894.5621.782.451.531.5316.349.361.092.484.64383,770.3010.0312.3312.3515.3028.2531.269.1712.131.945.310.3040.0016.8314.66-69.93-12.47-6.80--
Myomo Inc25.24m-8.38m145.39m101.00--15.66--5.76-0.2294-0.22940.68470.30721.513.118.08249,892.40-50.25-81.78-81.40-115.2770.0368.50-33.22-85.761.62--0.00--23.7051.0924.00--2.82--
Acme United Corp190.49m19.52m153.38m645.008.411.447.110.80524.944.9446.9028.771.182.095.84295,331.7012.137.0914.258.2939.3735.7210.255.501.917.060.233718.81-1.276.88486.3131.089.024.84
EUDA Health Holdings Ltd3.81m-17.99m154.21m106.00------40.46-0.4821-0.44510.1487-0.16851.86--7.2135,957.55-876.41------22.05---472.08-----43.68-----1.54--66.17------
Cibus Inc2.96m-291.86m155.18m183.00--0.4488--52.41-16.39-16.390.154511.750.0043--3.0916,180.33-53.70-86.28-64.26-96.45-----12,400.74-792.07---2.660.0032--1,057.3350.41-1,484.44--18.53--
Akoya Biosciences Inc93.22m-60.35m156.91m330.00--7.05--1.68-1.22-1.221.890.44980.56051.936.34282,472.70-36.29---45.98--57.57---64.74--1.98-8.000.7755--29.09--10.36------
Stereotaxis Inc23.75m-22.08m158.31m122.00--13.67--6.67-0.265-0.2650.2850.2020.56321.145.04194,639.30-49.21-25.02-71.93-34.1259.2867.57-87.38-41.901.53--0.00---4.89-1.82-12.33--6.63--
InfuSystem Holdings Inc129.37m366.00k166.47m499.00498.723.1113.291.290.01570.01575.992.511.2210.386.44259,264.500.34654.600.4015.6949.6856.430.28294.071.641.970.38980.0014.4413.384,744.44--6.01--
Senseonics Holdings Inc24.04m-80.46m182.83m132.00--285.70--7.61-0.1323-0.13230.03950.07140.18152.585.99182,113.60-60.74-73.65-74.52-106.9712.04-40.41-334.69-649.862.89-10.930.5802--36.623.43-142.49---18.76--
Nevro Corp426.10m-77.44m189.40m1.22k--0.6891--0.4445-2.12-2.1211.697.370.72661.115.93350,697.90-13.21-13.64-15.59-16.6868.0668.54-18.18-20.673.53-28.950.4433--4.631.88-3,172.74--0.9012--
SANUWAVE Health Inc24.90m-3.43m189.46m31.00------7.61-3.55-3.558.17-12.561.243.908.34803,064.50-17.07-136.54----71.5769.13-13.79-189.600.09990.1199----21.8461.61-150.72------
Data as of Nov 08 2024. Currency figures normalised to EUDA Health Holdings Ltd's reporting currency: US Dollar USD

Institutional shareholders

2.50%Per cent of shares held by top holders
HolderShares% Held
Hudson Bay Capital Management LPas of 30 Jun 2024800.00k2.28%
Citadel Securities LLCas of 30 Jun 202433.25k0.10%
Walleye Capital LLCas of 30 Jun 202416.57k0.05%
Geode Capital Management LLCas of 30 Jun 202416.04k0.05%
UBS Securities LLCas of 30 Jun 202410.62k0.03%
Yakira Capital Management, Inc.as of 30 Jun 20240.000.00%
XTX Markets LLCas of 30 Jun 20240.000.00%
Renaissance Technologies LLCas of 30 Jun 20240.000.00%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.